title: A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine.
authors.affiliation: University of Texas Medical Branch, Galveston, TX, USA. jagrant@utmb.edu
authors.forename: J A
authors.initials: JA
authors.lastname: Grant
authors.forename: L
authors.initials: L
authors.lastname: Danielson
authors.forename: J
authors.initials: J
authors.lastname: Rihoux
authors.forename: C
authors.initials: C
authors.lastname: DeVos
mesh_terms: D002090:Butyrophenones / Q000494:pharmacology*; D017332:Cetirizine / Q000494:pharmacology*; D018592:Cross-Over Studies; D003984:Dibenzazepines / Q000494:pharmacology*; D004311:Double-Blind Method; D006632:Histamine / Q000009:adverse effects* / Q000276:immunology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology*; D017336:Loratadine / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects / Q000276:immunology; D012882:Skin Tests; D016593:Terfenadine / Q000031:analogs & derivatives* / Q000494:pharmacology*
chemical_list: D002090:Butyrophenones; D003984:Dibenzazepines; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D010880:Piperidines; D017336:Loratadine; D016593:Terfenadine; D006632:Histamine; C093230:fexofenadine; C053090:epinastine; C058249:ebastine; D017332:Cetirizine